I Care Consult ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  10.6% 9.7% 13.0% 10.4% 7.9%  
Credit score (0-100)  23 24 17 23 9  
Credit rating  B B B B B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  33.8 667 1,052 1,122 1,074  
EBITDA  33.8 587 879 327 376  
EBIT  33.8 587 879 327 376  
Pre-tax profit (PTP)  14.2 584.2 878.3 327.4 375.9  
Net earnings  14.2 584.2 878.3 327.4 364.0  
Pre-tax profit without non-rec. items  14.2 584 878 327 376  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -2,598 -2,013 -1,135 -808 -444  
Interest-bearing liabilities  2,530 2,188 1,313 820 621  
Balance sheet total (assets)  128 207 223 153 326  

Net Debt  2,528 2,141 1,296 805 520  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  33.8 667 1,052 1,122 1,074  
Gross profit growth  0.0% 1,869.9% 57.9% 6.7% -4.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 -79.4 -173.5 -795.1 -698.5  
Balance sheet total (assets)  128 207 223 153 326  
Balance sheet change%  -70.8% 62.0% 8.0% -31.7% 113.9%  
Added value  33.8 666.7 1,052.4 1,122.5 1,074.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 88.1% 83.5% 29.2% 35.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.2% 23.7% 49.1% 28.2% 43.4%  
ROI %  1.2% 24.9% 50.2% 30.7% 52.2%  
ROE %  5.1% 349.5% 408.6% 174.2% 152.0%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  -95.3% -90.7% -83.6% -84.1% -57.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  7,468.9% 364.6% 147.5% 246.0% 138.5%  
Gearing %  -97.4% -108.6% -115.6% -101.5% -139.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.7% 0.1% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.0 0.1 0.2 0.2 0.4  
Current Ratio  0.0 0.1 0.2 0.2 0.4  
Cash and cash equivalent  2.6 46.5 16.4 14.5 100.8  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -2,597.7 -2,013.5 -1,135.2 -807.8 -443.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0